- Holgate ST. The role of mast cells and basophil s in inflammation, din Exp Allergy 2000;30:28-32.
- Raithel M, Winterkamp S, Pacurar A, Ulrich P, Hochberger J, Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol 2001;36:174-9.
- Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, FaIk W. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 1999;45: 210-7.
- Yamagata K, Tanaka M, Kudo H. A quantitative immunohistological evaluation of inflammatory cells at the affected and unaffected sites of inflammatory bowel disease. J Gastroenterol Hepatol 1998; 13:801-8.
- King T, Biddle W, Bhatia P, Moore J, Miner PB Jr. Colonie mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig Dis Sci 1992;37:490-5.
- Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein LM. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990:99:119-24.
- Nolle H, Spjeldnaes N, Kmse A, Windelborg B. Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut 1990;31:791 -4.
- Baum CA, Bhatia P, Miner PB. Increased colonie mucosal mast cells associated with severe watery diarrhea and microscopic colitis. Dig Dis Sci 1989;34:1462-5.
- Sommers SC. Mast cells and paneth cells in ulcerative colitis. Gastroenterology 1966;51:841-8.
- Hiatt RB, Katz L. Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol 1962;37:541 -5.
- Goldsmith P, McGarity B, Walls AF, Church MK, MillwardSadler GH, Robeitson DAF. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990;35:1409-13.
- Dvorak AM, Monahan RA, Osage JE, Dickersin GR. Crohn's disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol 1980;11: 606-19.
- Dvorak AM, Monahan RA, Osage JE, Dickersin GR. Mast-cell degranulation in Crohn's disease. Lancet 1978;1:498.
- Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978;52:447-52.
- Niwa Y, Kasugai T, Ohno K, Morimoto M, Yamazaki M, Dohmae K, et al. Anemia and mast cell depletion in mutant rats that are homozygous at 'white spotting (Ws)' locus. Blood 1991; 78:1936-41.
- Sands BE. Therapy of inflammatory bowel disease. Gastroenterology 2000;118:868-82.
- Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaga R. A novel method in the induction of reliable experimental acute and chronic colitis in mice. Gastroenterology 1990;98:694-702.
- Ni J, Chen SF, Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1996;39:234-41.
- Porter SN, Howarth GS, Butler RN. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in oolitic rats. Scand J Gastroenterol 1998;33:967-74.
- Morris GP, Beck PL, Henidge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
- Kim HS, Berstad A. Experimental colitis in animal models [Review]. Scand J Gastroenterol 1992;27:529-37.
- Torres MI, Garcia-Martin M, Fernandez MI, Nieto N, Gil A, Rios A. Experimental colitis induced by trinhrobenzenesulfoni c acid: an ultrastructural and histochemical study. Dig Dis Sci 1999;44: 2523-9.
- Minocha A, Thomas C, Omar R. Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice. Dig Dis Sci 1995;40:1757-62.
- Araki Y, Andoh A, Fujiyama Y, Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 2000;119:264-9.
- Chin KW, Barren KE. Mast cells are not essential to inflammation in murine model of colitis. Dig Dis Sci 1994;39: 513-25.
- Reed JA, McNutt NS, Bogdany JK, Albino AP. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol 1996;23:495-505.
- Gelbmann CM, Barrett KE. Role of histamine in a rat model of colitis. Inflamm Res 1995;44:386-92.
- Longo WE, Polities G, Vemava AM 3rd, Deshpande Y, Niehoff M, Chandel B, et al. Platelet-activating factor mediates trinitrobenzene induced colitis. Prostaglandins Leukot Essent Fatty Acids 1994;51:419-24.
- Nishikawa M, Hikasa Y, Hori K, Tanida N, Shimoyama T. Effect of leukotriene C4D4 antagonist on colonie damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats. J Gastroenterol 1995;30:34-40.
- Gaffiiey PR, O'Leary JJ, Doyle CT, Gaffhey A, Hogan J, Smew F, et al. Response to heparin in patients with ulcerative colitis. Lancet 1991;3374:238-9.
- Fries W, Pagiaro E, Canova E, Carraro P, Gasparini G, Pomerri F, et al. The effect of heparin on trinitrobenzene sulphonic acidinduced colitis in the rat. Aliment Pharmacol Ther 1998;12:229-36.
- Tynell DJ, Home AP, Holme KR, Preuss JM, Page CP. Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol 1999;46:151-208.
- Andoh A, Kimura T, Fukuda M, Araki Y, Fujiyama Y, Bamba T. Rapid intestinal ischaemia-reperfusio n injury is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 1999;116:90-3.
- Arizono N, Kasugai T, Yamada M, Okada M, Morimoto M, Tei H, et al. Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats. Blood 1993;81:2572-8.
- Nishida M, Uchikawa R, Tegoshi T, Yamada M, Matsuda S, Sasabe M, et al. Lack of active lung anaphylaxis in congenitally mast cell-deficient Ws/Ws rats sensitized with the nematode Nippostrongylus brasiliensis. APMIS 1998;106:709-16.
- Sugihara A, Tsujimura T, Pujita Y, Nakata Y, Terada N. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 1999; 30:859-67.
- Higa A, Abe T, Yoshida T, Tanaka K, Nawa Y. The possible role of LTC4 in the pathogenesi s of ethanol-induce d gastric lesions in mice and their prevention by 5-lipoxygenas e inhibitor AA-861, and leukotriene receptor antagonist FPL-55712. Gastroenterol Jap 1991;26:1-6.
- Higa A, Ishikawa N, Eto T, Nawa Y. Evaluation of the role of mast cells in the progression of acetic acid-induced colitis in mice. Scand J Gastroenterol 1996;31:774-7.
- Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol Gastrointest Liver Physiol 1995;269:G119-25.
- Qiu BS, Vallance BA, Bleimerhassett PA, Collins SM. The role of CD4+ lymphocytes in the susceptibility of mice to stressinduced reactivation of experimental colitis. Nat Med 1999;5: 1178-81
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 5